chrisvoncsefalvay/vaers-outcomes huggingface dataset:
She explained both of their "arms are sore"; she was "nauseous" this morning.; This is a spontaneous report from a contactable consumer. A 41-year-old female consumer (patient) reported for herself that she received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number: unknown, Expiration date: Not reported) via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient reported that she herself and her 50-year-old husband received their first dose of the vaccine the day before at a drive-through. She explained that both of their arms were sore and she was nauseous that morning. She also said the pain was killing her. She asked if it's true that pain medication cannot be taken post-vaccination. Outcome was unknown for all the events.    No follow-up attempts are needed; information about lot/batch number cannot be obtained.
The patient is a healthy 13 mo old female with a history of eczema who received hep A #1, PREVNAR #4, MMR and varicella vaccine on 18 May 2017 and developed HSP with onset day 11. She initially did fine post vaccine but developed 101.8 fever on day 8 and was treated with TYLENOL. She developed EM like targetoid lesions to extremities followed on day 12 by edema ankles, then edema to face, wrist and lesions to face, extremities, trunk and buttocks. Lesions were macular, raised, fixed, blanching, and on thighs mildly pruritic although that is an eczema site. The buttock lesions progressed to ecchymotic and has scattered purpura. She is doing well and improving. She has had three episodes of watery diarrhea 01 and 02 JUN 2017, but otherwise eating OK, at most slightly decreased. She is more clingy but no other more specific evidence of systemic symptoms such as myalgias, arthralgias, nausea, no emesis, no change in urine, no evidence of pain, no increased sleep or fatigue. Family reports no immediate adverse event after receipt suggestive of IgE such as oral/facial/throat or tongue swelling. No local site reaction. Other than noted above, no systemic symptoms. No other illness symptoms. She was treated with BENADRYL and hydrocortisone cream. Dermatology diagnosed Henoch-Schonlein Purpura Vasculitis.
He tested positive for COVID-19 on 3/20/23. He had a cough, fever and lethargic. We contacted his doctor and was prescribed a fluticasone, had to take his albuterol inhaler every 4 hours for 4 days. We also gave him TYLENOL and ibuprofen. He is feeling much better now.
Initial pregnancy report received from a healthcare professional on 10 April 2013. A 39-year-old female patient, had received the first dose of ADACEL vaccine (batch number: C4344AA, expiry date: 06/04/2015, site of administration was not reported) intramuscularly on 09 April 2013. The patient's medical history and concomitant medications were not reported. The patient was 17 weeks pregnant with twins. The patient had no specific risk factors. The patient's date of last menstrual period and estimated delivery date were not reported. At the time of this report, the patient had not experienced any adverse events. Document held by sender: none. Follow up information received from healthcare professional on 20 June 2013. The patient had received vaccine on right arm. The patient received KEFLEX, Prenatal kit and Iron as concomitant medications. The patient's LMP date was December 2012 (date was unspecified) and EDD date was reported as 25 August 2013. The patient had unspecified prenatal tests on an unspecified date in May 2013.
Sore muscles just in the arm and shoulder where the vaccine injection was given; Sore muscles just in the arm and shoulder where the vaccine injection was given; Really tired; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A male patient received bnt162b2 (BNT162B2), administration date 05Feb2021 (Lot number: EN6204) as dose 1, single for covid-19 immunisation. Relevant medical history included: "COVID-19", start date: Oct2020 (unspecified if ongoing); "Surgery", start date: Jan2021 (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: VACCINATION SITE PAIN (non-serious), MYALGIA (non-serious), outcome "unknown" and all described as "Sore muscles just in the arm and shoulder where the vaccine injection was given"; FATIGUE (non-serious), outcome "unknown", described as "Really tired".  Additional information: It was reported that the patient's symptoms were very mild.  No follow-up attempts are possible. No further information is expected.
Information was received from a lawyer regarding a case in litigation involving a female patient, age and medical history not provided. On or about 21-JUL-2014 the patient was inoculated with ZOSTAVAX vaccine at a pharmacy for routine adult health maintenance and the prevention of shingles.  The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain condition of herpes zoster. On or about 24-MAY-2016 the patient was treated at urgent care for a blistering vesicular outbreak, and decreased immune system which was diagnosed as severe shingles. The patient was prescribed acyclovir for management of her pain symptoms and chronic pain. As a direct and proximate result of ZOSTAVAX or despite receiving ZOSTAVAX for prevention of shingles, the patient suffered painful injuries and damages and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, pain, suffering and other damages. Additional information has been requested.
Lots of people got the jab and have gotten shingles / Suspected vaccination failure; Lots of people have gotten shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in an unspecified number of patients who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional case details were reported as follows: The age at vaccination was not applicable for this report.. The reporter knew lots of people who had gotten shingles in the past months. All of them get the jab and reporter did not know one unvaxxed person who had shingles. This case was considered as suspected vaccination failure, as details regarding completion of primary vaccination schedule, laboratory test confirmation and time to onset for shingles were unknown at the time of reporting. The follow up was not required.
THERE WERE NO SIDE EFFECTS.  WE CALLED PATIENT TO REVACCINATE PATIENT 4 WEEKS AFTER THE ADVERSE
pt 4.5 hr post vax devel a tight throat, swollen lips, chest tightness & numbness of the lower face & jaw;tightness lasted 20min, numbness & swelling cont;tx w/DPH;
pt recv vax 18AUG97 that evening exp a brief focal sz;afebrile;parents took pt to ER & was hosp;MD indicated that pt exp an apparent self limited sz & recovered;
A half hour after receiving vaccine, pt got head cold symptoms, nausea, and vomiting.  Lasted a few hours for vomiting.  The next day felt better but had a "hung over" feeling.
*Extreme headache, to the point I could not function, extreme flu-like symptoms, extreme nausea, extreme vomiting,  Both shots made me very sick, to the point I could not work, however, I was still required to report to work as I am considered an essential employee in my state
Patient presented to the ED on 6/7/21 with worsening redness and swelling of his legs. He had presented to the ED with the same complaints on 5/29/21 but was discharged back to his group home. On the 5/29 visit, he was tested for COVID as part of standard protocol, and was found to be COVID positive (asymptomatic) despite receiving 2 doses of Pfizer vaccine (1/15 and 2/5). On the 6/7 ED visit, pt was initially found to be hypoxic (89% on room air) in the ED, but once he was admitted and transferred to the COVID floor, he was found to be 95% on room air and supplemental O2 was discontinued. Patient has remained asymptomatic for COVID during his hospitalization, and has not required COVID treatment.
Headache, Small fever of 101 degrees,  joint aches especially on right side (previous neuro issue side), chills, fatigue. Lasted roughly 2-3 days.
On day 8 after vaccine administered I developed a red rash at the earlier inoculation site.  The site was sore and icy hot and felt as if I had just been administered a flu shot.  This is the second day of the reaction and it is still sore and feels icy hot with the rash the same.  It involves my Left upper arm exactly where I had been inoculated.
This spontaneous case was reported by a consumer and describes the occurrence of SUSPECTED COVID-19 (COVID), ASTHENIA (Don't feel very energetic), POOR QUALITY SLEEP (Couldn't even sleep), PERIPHERAL COLDNESS (Cold feet) and PAIN (Extreme pain) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm pain that resembles rotor cup issues). On an unknown date, the patient experienced SUSPECTED COVID-19 (COVID), ASTHENIA (Don't feel very energetic), POOR QUALITY SLEEP (Couldn't even sleep), PERIPHERAL COLDNESS (Cold feet), PAIN (Extreme pain), MYALGIA (Body aches), ARTHRALGIA (Joiint pain), CHILLS (Extreme chills), HEADACHE (Dull head ache) and PYREXIA (Feverish). The patient was treated with IBUPROFEN ongoing since an unknown date at a dose of 600 milligram once a day and ACETAMINOPHEN at a dose of 500 milligram. On 19-Mar-2021, PAIN IN EXTREMITY (arm pain that resembles rotor cup issues) outcome was unknown. At the time of the report, SUSPECTED COVID-19 (COVID), ASTHENIA (Don't feel very energetic), POOR QUALITY SLEEP (Couldn't even sleep), PERIPHERAL COLDNESS (Cold feet), PAIN (Extreme pain), MYALGIA (Body aches), ARTHRALGIA (Joiint pain), CHILLS (Extreme chills), HEADACHE (Dull head ache) and PYREXIA (Feverish) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient used Heating pad under the feet conducted as a treatment for cold feet.
Heart Palpatations. Tests, blood work, medication. Still have them all test negative for heart problems.
PHN administered Moderna boosters at client's retirement residence.   Client was present with wife and residency staff member.  Staff member filled out the form for the client.  White COVID card was reviewed prior to injection and only the first two doses of the primary series were documented.  PHN asked client if he consented to getting his Moderna Booster and he did consent.  After dose was administered, back at the office, dose was documented  and noted that a Moderna Booster had already been given to client the day before by his PCP office.
Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Medium, Systemic: Flushed / Sweating-Medium, Systemic: Hypotension-Medium, Systemic: Nausea-Medium
pt recv vax 12MAY97 & 12MAY97 pt exp nausea, fatigue, weakness, h/a, fever, aching joints & malaise;sx lasted for approx 24 to 30hr;
Information has been received concerning a pt who was vaccinated on 06/15/00 with one dose of varicella vaccine. The next day the pt developed induration of 10 cm, erythema and tenderness at the injection site. It was noted that the pt was afebrile. Antibiotic therapy was started as a precautionary measure and the pt recovered about one week later.
bilateral arm pain and sore throat starting within 24 hours of vaccination and lasting 4 days
Persistent fever, chills, aches, and fatigue over 72-hr period.  Patient bedridden for duration of symptoms.
CASE RECEIVED TDAP AND INFLUENZA VACCINES AT A FLU CLIN, 15-20 MINUTES LATER HAD SUDDEN ONSET OF NAUSEA, DIAPHORESUS, DIARRHEA AND NEAR SYNCOPAL EPISODE. SHE HAS HISTORY OF HTN AND BEFORE INCIDENT BP 152/98, FIFTEEN MINUTES AFTER BP 114/66. SHE DESCRIBES RESOLUTION OF SYMPTOMS 20 MINUTES AFTER ONSET, TO ER FOR OBSERVATION ONLY.
Patient scheduled an appointment today with left facial side numbness that started on 4/21/21. Reports that on 4/20 she felt pain on left side of face. Received covid vaccine on 4/19 and wondered if related. On 4/24 noticed that she was unable to smile due to mild facial droop on left side. No other ill symptoms.
Information has been received from a Nurse Practitioner concerning a female who on an unspecified date was vaccinated with a 0.65ml dose of zoster vaccine live (Oka/Merck). Subsequently the patient developed shingles. Unspecified medical attention was sought. At the time of the report the patient's status was unknown. There was no product quality complaint involved. Additional information has been requested.
Headache, Shortness of Breath, Hard bump around injection site, and redness.
Patient reported that, the night after vaccination, she experienced a significant raise in temperature at her right thigh. The area was hot to touch, and it persisted the entire night. The reaction resolved the next morning. Patient denied pain, itchy, numb, or any other discomfort other than raise in temp, and patient said she could walk without any problem. Patient also reported rash on her right arm (despite site of injection being left) and joint pain.
the evening of 2/24/2022 to discuss patient's COVID positive results and the need to defer his procedure 20 days per policy. APRN is aware of the positive results and agreed with the plan. Patient understandably was disappointed about deferring his procedure, but understood
sore throat; her arm was a little sore; hoarseness/raspiness of the voice; pressure in the chest; This is a spontaneous report from a contactable consumer or other non-HCP. A female patient of an unspecified age(Age: 71; Unit: Unknown)  received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported), via an unspecified route of administration on 27Feb2021 as DOSE 1, SINGLE (Age of vaccination: Unknown) for covid-19 immunization. The patient's medical history and concomitant medications were not reported. On 27Feb2021 the patient experienced sore throat, her arm was a little sore, hoarseness and raspiness of the voice and pressure in the chest. The outcome of event her arm was a little sore was unknown while outcome of rest all events was recovered on 27Feb2021  No follow up attempts are possible; information on Lot/batch number cannot be obtained.
Guest received a flu shot, Standard. He was fine and waited about 10-15 minutes. Watched his wife receive her shot, walk away to get something, became dizzy and fainted. Paramedics came took his vitals, he refused going to the hospital stating this has happen to him in the past, usually when giving blood and it had not happen in a while so he thought he was fine. He stated if he goes home and rest he would be fine.
2 week later,light pink around injection site; Developing a rash and redness spreading; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOLOURATION (2 week later,light pink around injection site) and VACCINATION SITE RASH (Developing a rash and redness spreading) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included SACUBITRIL VALSARTAN SODIUM HYDRATE (ENTRESTO) for an unknown indication.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE DISCOLOURATION (2 week later,light pink around injection site) and VACCINATION SITE RASH (Developing a rash and redness spreading). At the time of the report, VACCINATION SITE DISCOLOURATION (2 week later,light pink around injection site) and VACCINATION SITE RASH (Developing a rash and redness spreading) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medication includes Thyroid pill.
1 and 1/2 in x 1 and 1/2 hematoma quickly developed for small framed elderly female. Patient did not have any numbness or pain.  Instructed patient to ice and watch for signs of symptoms of numbness or increase in swelling and if so to seek medical attention.
I started feeling sick on Tuesday evening the 10th by the next morning, I was I worse. I had a bad cough and was very fatigued and started feeling a sore throat. I took a CoVID test and that was negative. The next day I had a low grade fever and the cough was worse and I was so tired and out of it. Thursday I tested again and it was positive. I reached out to my PCP and they got me Paxlovid which has helped. At this point I have really only a small cough left but am feeling much better
Red, rash noted on 11/29/18. Notes to be resolving on 11/30/2018.
fever (3 hours), nausea (3 hours), coughing (2 days), sore throat (16 hours), muscle ache (in areas other than injection site), headache (2 hours), fatigue (4 hours)
Information has been received from a nurse concerning a 4 year old male with no pre-existing physician diagnosed allergies, birth defects, or medical conditions who on 10/02/2000 was vaccinated with a dose of varicella virus vaccine live.  Concomitant therapy that day included a dose of hepatitis b virus vaccine rHBag.  There was no other vaccinations within 4 weeks prior to 10/02/2000.  On 05/22/2004 in the PM, the patient developed red spots all over his body, and it was getting worse.  The patient was diagnosed with chickenpox.  The patient was treated with diphenhydramine hydrochloride and aveeno as needed.  There were no relevant diagnostic or laboratory tests.  The outcome was reported as recovered.
Pt received a vaccination from an expired lot number.  Guardian did not provide a good contact phone number and after all attempts to locate a number from records were exhausted; health unit nurse manager emailed the parent and instructed her to contact the health unit at her earliest convenience. Patient's guardian was contacted by health unit nurse manager and provided information from manufacturing company and CDC.  Nurse manager instructed guardian to continue to monitor minor for any side effects and to consult with her pediatrician for follow-up regarding the event and repeating of the vaccination.  Vaccination completed on Thursday afternoon, 9/16  prior to closing of health unit and attempts to contact the parent began on Friday, 09/17.  Nurse manager received a call from the parent on Monday, 09/20
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Physician) from product quality group. The reporter is the patient.  A 66-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 28Dec2020 as dose 1, single (Lot number: EL0140), in right arm, on 18Jan2021 as dose 2, single (Lot number: EK9231), in right arm, on 30Sep2021 as dose 3 (booster), single (Lot number: FE3592), in right arm and on 21Apr2022 as dose 4 (booster), single (Lot number: FJ9943) at the age of 66 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Hypothyroidism" (unspecified if ongoing). Concomitant medication(s) included: SYNTHROID oral. Past drug history included: Trimethoprim, reaction(s): "Known allergies: trimethoprim"; Sulfamethoxazole, reaction(s): "Known allergies: sulfamethoxazole".  The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown Results, notes: indication was Treatment of COVID-19. Therapeutic measures were taken as a result of vaccination failure, covid-19. Anti viral treatment was started from 20Jul2022 to 25Jul2022 by oral route.; Sender's Comments: Based on the available information, the reported events cannot be excluded for the suspect drug.
father phoned clinic & reported that pt has red strawberry rash, raised sl like a hive, about 3" below inject site rt deltoid; t100;
Information has been received from an RN concerning a female who was vaccinated with pneumococcal vaccine 23 polyvalent and 1 1/2 to 2 hours, post vax, she experienced arm, breast and back swelling on the side of injection. The pt sought medical attention and was treated with antihistamines, antibiotics and pain medication. The outcome of the pt's experience was unknown. Upon internal review, the pt's experiences were considered an "Other Medical Event". Additional information has been requested.  Follow up on 03/28/2001: "Patient date of birth, patient age at time of vaccination, adverse event onset date/time, vaccine administration date/time is not provided."
very tired / extremely tired; has no energy; This is a spontaneous report from a contactable consumer. A 82-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EL2966), via unspecified route of administration on 28Mar2021 as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Historical vaccine included BNT162B2 for COVID-19 immunization. It was reported that patient had very tired since the second dose she had no energy and extremely tired, which was not normal for her. The outcome of events was unknown.   No follow-up attempts are possible. No further information is expected.
Pt recvd vax & exp nausea, vomiting, diarrhea, fever (103 degrees fahrenheit), sore throat, pale, cough & runny nose, 7FEB93 the pt again went to ER; sx subsided;